Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

Deregulated mRNA translation has been implicated in disease development and in part is controlled by a eukaryotic initiation complex eIF4F (composed of eIF4E, eIF4G and eIF4A). We demonstrate here that the cap bound fraction from lymphoma cells was enriched with eIF4G and eIF4E indicating that lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Demosthenous, Christos, Han, Jing Jing, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Link, Brian, Hege, Kristen, Dogan, Ahmet, Sotomayor, Eduardo, Witzig, Thomas, Gupta, Mamta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496233/
https://www.ncbi.nlm.nih.gov/pubmed/25839159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496233/
https://www.ncbi.nlm.nih.gov/pubmed/25839159

Ejemplares similares